Z92.850 ICD-10-CM Code: Personal history of Chimeric Antigen Receptor T-cell therapy
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Factors influencing health status and contact with health services (Z00-Z99) / Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Z92.850
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidancePersonal history of Chimeric Antigen Receptor T-cell therapy
A patient has previously received CAR-T cell therapy, an advanced cancer treatment where immune cells are genetically modified to fight cancer.
CMS-HCC V28
00
RAF 0
CMS-HCC V24
00
RAF 0
ACA/HHS
00
RAF 0
ESRD/PACE
00
RAF 0
RXHCC
00
RAF 0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
Official- Personal history of CAR T-cell therapy
Excludes 2
Official- personal history of immune checkpoint inhibitor therapy (Z92.26)
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for Z92.850 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for Z92.850 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for Z92.850 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for Z92.850 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for Z92.850 in this effective period.
Buddy Documentation Tip
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is Z92.850 an HCC code?
No. Z92.850 is a billable ICD-10-CM code but does not map to any HCC category in V28, V24, ESRD, or RxHCC.
This code does not map to an HCC category in any model (V28, V24, ESRD, RxHCC).
What This Code Means
Z92.850 is the ICD-10-CM diagnosis code for personal history of chimeric antigen receptor t-cell therapy. A patient has previously received CAR-T cell therapy, an advanced cancer treatment where immune cells are genetically modified to fight cancer. Z92.850 sits in the ICD-10-CM chapter for factors influencing health status and contact with health services (z00-z99), within the section covering persons with potential health hazards related to family and personal history and certain conditions influencing health status (z77-z99).
Z92.850 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.
Document the type of cancer treated and the date of CAR-T therapy for monitoring long-term effects.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for Z92.850 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Document the type of cancer treated and the date of CAR-T therapy for monitoring long-term effects
- •Important for tracking potential complications like cytokine release syndrome or neurological toxicity that can occur months after treatment